Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gestational trophoblastic disease.

Elizabeth I O Garner1, Donald P Goldstein, Colleen M Feltmate

  • 1Brigham and Women's Hospital, New England Trophoblastic Disease Center, Boston, Massachusetts, USA. egarner@partners.org

Clinical Obstetrics and Gynecology
|February 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Twin molar pregnancy: a diagnostic framework for early recognition and appropriate management.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2026
Same author

Checkpoint Inhibition in Gestational Trophoblastic Neoplasia: A Narrative Review on the Reawakening of Antitumor Immunity.

Advances in therapy·2026
Same author

Home-based treatment of low-risk gestational trophoblastic neoplasia with 8-day methotrexate/folinic acid.

Gynecologic oncology·2025
Same author

Phenotypic Alteration and Suppression of Cytotoxicity of Decidual NK Cells After Co-culturing With Different Trophoblastic Cell Lines.

Anticancer research·2025
Same author

Insights from plastic and reconstructive surgery wound specialists in managing complex vaginal and vulvar toxicities following radiation therapy.

Gynecologic oncology reports·2025

Hydatidiform mole diagnosis is evolving, with earlier detection revealing subtler pathology. Research into familial syndromes and updated follow-up protocols for complete and partial molar pregnancy are key areas of focus.

Area of Science:

  • Reproductive Medicine
  • Genetics
  • Pathology

Background:

  • Hydatidiform mole, a fertilization disorder, includes complete and partial types.
  • Earlier diagnosis of complete molar pregnancy presents with more subtle pathologic findings.
  • Familial syndromes of recurrent hydatidiform mole are rare but documented.

Purpose of the Study:

  • To review the changing clinical presentation of complete molar pregnancy due to earlier diagnosis.
  • To highlight the increasing use of immunohistochemical techniques for diagnosing molar pregnancies.
  • To discuss the management and follow-up of hydatidiform mole, including familial cases and postmolar neoplasia surveillance.

Main Methods:

  • Review of current literature on hydatidiform mole diagnosis and management.

Related Experiment Videos

  • Discussion of pathologic and clinical features, emphasizing changes due to early detection.
  • Exploration of ancillary diagnostic testing, including immunohistochemistry for imprinted genes.

    • Main Results:

    • Earlier diagnosis of complete mole is associated with more subtle pathologic findings.
    • Immunohistochemical detection of maternally imprinted genes is increasingly used.
    • Shorter postmolar follow-up periods may be suitable for both complete and partial molar pregnancies.

    Conclusions:

    • The diagnosis and presentation of hydatidiform mole are evolving, necessitating updated diagnostic approaches.
    • Further research is needed to identify genetic defects in familial recurrent molar pregnancies.
    • Current evidence suggests that modified hCG follow-up protocols may be appropriate post-molar pregnancy, balancing surveillance with patient convenience.